Gland Pharma announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Pashamylaram facility at Hyderabad.

SEBI issued a new framework for the index-derivatives segment, including reducing contracts with weekly expiries, increasing ...

Laura Citron, London & Partners “There was so much riding on it,” recalls Laura Citron of the multi-million pound Let’s Do London campaign to revitalise travel back to the capital. “The tourism sector ...

Fintel reports that on January 17, 2025, Evercore ISI Group downgraded their outlook for Warby Parker (NYSE:WRBY) from ...